Nine Additional Requirements for Antiseptics and Disinfectants: Article 6.3.2.4

1. Key takeaways

Article 6.3.2.4 of RTS 11.03.02:21 adds nine requirements for medical antiseptic and disinfectant products intended for hospital use (productos antisépticos y desinfectantes de uso médico hospitalario) on top of the twelve general items: a) the insert; b) the technical file supporting shelf life or stability; c) the conditions for preservation, storage and transport; d) the qualitative and quantitative formulation; e) the sterilisation certificate, where applicable; f) the technical file on container closure, where applicable; g) the document issued by the Ministry of Health registering a natural person as a user of alcohol, where applicable; h) the alcohol quota document issued by the Ministry of Finance, where applicable; i) the efficacy validation report. The total is twelve plus nine, that is twenty-one items.

The list is the longest of the four category lists, and two of its items reach outside the health regulator altogether. That external dimension is what makes the antiseptic and disinfectant category structurally different from the other three.

• Nine additional documents apply, for a total of twenty-one items.
• Two documents come from ministries other than the health regulator.
• Both cross-ministry documents are limited to alcohol-containing formulations.
• Aqueous alcohol solutions must meet the current NSO denatured ethanol standard.
• The efficacy validation report must support the kill claims printed on the label.
• Laboratory testing for this category sits in a named fee tier.

2. Legal basis

The additional items for antiseptics and disinfectants draw on the device definition, which includes disinfection among the purposes of a medical device, on the labelling rules and on the fee schedule. The table records each provision with the obligation attached to it.

3. Expert insights

First insight: items g and h pull device registration into cross-ministry regulation. The two documents are issued by different bodies: the Ministry of Health provides the registration of the natural person as a user of alcohol, and the Ministry of Finance provides the alcohol authorisation quota. This is the only place in the regulation where two non-device authorities must issue documents for a device file, and it is the real threshold for disinfectant products. An alcohol-containing formulation without a quota document cannot be filed at all, because the missing document is not something the applicant can replace with an equivalent.

Second insight: both items carry the phrase cuando aplique, and the determinant is whether the formulation contains alcohol. Article 6.3.2.4 g) and h) both close with the where applicable formula. Read with article 6.3.4 d), item 16, which requires aqueous alcohol solutions to comply with the current edition of the NSO denatured ethanol standard, the test is clear: alcohol-containing medical disinfectants need the two documents, while non-alcohol disinfectants are exempt. Recording the formulation decision in the file, with the percentage of alcohol stated, makes the exemption defensible if it is questioned at acceptance.

Third insight: the efficacy validation report under item i is direct evidence for the principle in article 5.2.1 c). Article 5.2.1 c) requires the device to perform as claimed by the manufacturer under normal conditions of use, and for a disinfectant the performance in question is the microbicidal or microbistatic effect. The item i report must therefore support the spectrum of activity and the contact time claimed on the label. Where it does not, the same label claim also engages article 6.5.4 a), under which advertising and promotion may not attribute qualities that have not been authorised.

Fourth insight: disinfectants occupy a named tier in the fee schedule, which signals a higher likelihood of sampling. Article 6.2.1 of the fee schedule places medical antiseptics and disinfectants together with surgical sutures and tracheal or tracheostomy tubes in the USD 750.00 laboratory testing tier. Of the four device tiers of 750, 1000, 1500 and 1200 US dollars, this is the one that names disinfectants expressly. Read with article 6.5.2 b), under which the cost of testing is borne by the device holder, the amount should be carried in the project budget from the outset rather than discovered at the sampling stage.

The quota document in particular is not a regulatory form that can be produced on request at filing time. It rests on an allocation of alcohol, so the quantity needed for the batches intended for El Salvador has to be anticipated before the application is assembled. That makes the commercial forecast part of the regulatory file, which is why disinfectant projects are usually planned backwards from the quota rather than forwards from the dossier.

4. Practical recommendations

• For an alcohol-containing formulation, confirm first whether the Ministry of Health alcohol user registration and the Ministry of Finance quota document can be obtained.
• For a non-alcohol disinfectant, state the reason for the where applicable exemption in the application, so that no request for additional documents follows.
• Make the efficacy validation report support the spectrum of activity and contact time claimed on the label.
• Check aqueous alcohol solutions against the current edition of the NSO denatured ethanol standard at the same time.
• Budget the USD 750.00 laboratory testing fee under article 6.2.1.
• Carry the lead time of the two cross-ministry documents in the project schedule, because neither sits inside the SRS process.

5. Verification checklist

• □ Alcohol content of the formulation determined
• □ Alcohol user registration obtained where alcohol is present
• □ Ministry of Finance alcohol quota document obtained where alcohol is present
• □ Efficacy validation report supports the label claims
• □ Aqueous alcohol solution complies with the current NSO standard
• □ Laboratory testing fee included in the budget

The regulations cited in this article are RTS 11.03.02:21, Dispositivos Médicos. Requisitos para la Regulación Sanitaria de Dispositivos Médicos (Acuerdo No. 14-2022, Diario Oficial No. 156, Tomo No. 436, 2022-08-23), articles 3.14 f), 5.2.1 c), 6.3.2.4 a)–i), 6.3.4 d) item 16, 6.5.2 b) and 6.5.4 a); and the Tarifario de la Superintendencia de Regulación Sanitaria (2025 edition, published on the SRS website in 2025-10), article 6.2.1.

Regulatory information verified as at 29 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Salvadoran market. Our team manages Ministry of Health (MINSAL) sanitary registration applications, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com